Published in J Immunol on October 01, 1969
In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. Proc Natl Acad Sci U S A (1972) 2.29
Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect Immun (1977) 2.24
Cell-mediated immune response to influenza virus infections in mice. Infect Immun (1976) 1.90
Humoral and cellular response in humans after immunization with influenza vaccine. Infect Immun (1973) 1.54
Specific and nonspecific cell-mediated resistance to influenza virus in mice. Infect Immun (1974) 1.50
In vitro assessment of cellular immunity to vaccinia virus: contribution of lymphocytes and macrophages. Infect Immun (1970) 1.46
Cell-mediated immunity to Sendai virus infection in mice. Infect Immun (1977) 1.12
In vitro delayed hypersensitivity in normal and hyporeactive patients. Immunology (1971) 1.11
Inhibition of migration of mouse macrophages by tuberculin-sensitive mouse lymphocytes and by mouse migration inhibitory factor. Infect Immun (1973) 1.06
In Vivo and In Vitro Studies of Delayed-Type Hypersensitivity to Toxoplasma gondii in Guinea Pigs. Infect Immun (1971) 1.00
In vitro evaluation of cell-mediated immunity in mice: experiments with soluble and cellular antigens in a spleen-thymus cell leucocyte migration test (LMT). Clin Exp Immunol (1971) 0.93
Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures. Clin Exp Immunol (1975) 0.91
Delayed-type hypersensitivity responses in mice infected with St. Louis encephalitis virus: kinetics of the response and effects of immunoregulatory agents. Infect Immun (1979) 0.82
The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens. J Hyg (Lond) (1975) 0.78
Induction and in Vitro demonstration of cellular immunity to DNA and RNA viruses in guinea-pigs. Clin Exp Immunol (1975) 0.77
The role of membrane association of antigens in induction of cell-mediated immunity to viruses. Clin Exp Immunol (1978) 0.77
Cell-mediated immunity on secretory surfaces. J Natl Med Assoc (1972) 0.75
Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis (1981) 14.19
Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol (1985) 10.22
Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun (1982) 9.97
Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol (1993) 8.47
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science (1997) 7.53
Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol (1993) 6.36
Mannose binding and epithelial cell adherence of Escherichia coli. Infect Immun (1978) 5.99
Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science (1973) 5.82
Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med (1976) 5.55
Cell membrane-binding properties of group A streptococcal lipoteichoic acid. J Exp Med (1975) 5.30
Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. J Virol (2000) 5.26
Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. J Virol (1996) 4.59
Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol (1983) 4.40
A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A (1993) 4.30
Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili. J Infect Dis (1974) 4.15
Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15
Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1989) 3.67
Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62
Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A (2004) 3.57
Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39
Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38
Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol (1993) 3.37
Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31
Detection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. I. Methodology and immunologic properties of pneumococcal antigens. J Lab Clin Med (1973) 3.30
Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J Clin Microbiol (1989) 3.19
Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect Immun (1981) 3.18
Determination of aetiology of bacterial meningitis by counter-immunoelectrophoresis. Lancet (1972) 3.18
Adherence of group A streptococci to fibronectin on oral epithelial cells. Infect Immun (1983) 3.11
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit. J Bacteriol (1986) 2.93
Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92
Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89
Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect Immun (1983) 2.85
Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med (1982) 2.84
Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol (1987) 2.83
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science (1979) 2.78
Enzyme-linked immunosorbent assay for detection of hepatitis A antigen in stool and antibody to hepatitis A antigen in sera: comparison with solid-phase radioimmunoassay, immune electron microscopy, and immune adherence hemagglutination assay. J Clin Microbiol (1978) 2.64
Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med (1985) 2.61
Detection of flaviviruses by reverse-transcriptase polymerase chain reaction. J Med Virol (1991) 2.59
Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med (1971) 2.59
Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A (1987) 2.56
Detection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. II. Etiologic diagnosis of pneumococcal pneumonia. J Lab Clin Med (1973) 2.55
Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med (1985) 2.53
Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells. Infect Immun (1983) 2.48
Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology (1996) 2.44
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Clinical and serological analysis of transfusion-associated hepatitis. Lancet (1975) 2.41
Excretion of lipoteichoic acid by group A streptococci. Influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. J Clin Invest (1978) 2.40
Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination. J Virol (1991) 2.36
Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J (1996) 2.35
Binding of group A streptococci to human oral mucosal cells by lipoteichoic acid. Trans Assoc Am Physicians (1975) 2.32
Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. J Bacteriol (1987) 2.26
Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man. J Immunol (1969) 2.25
Detection by immunoelectrophoresis of antigen in sera of patients with pneumococcal bacteraemia. Lancet (1971) 2.24
Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae. Nature (1988) 2.24
Formation of molecular complexes between a structurally defined M protein and acylated or deacylated lipoteichoic acid of Streptococcus pyogenes. J Bacteriol (1982) 2.22
Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest (1982) 2.19
Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun (1974) 2.18
Adherence pharyngeal and skin strains of group A streptococci to human skin and oral epithelial cells. Infect Immun (1977) 2.17
Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun (1973) 2.13
Interference with the mannose binding and epithelial cell adherence of Escherichia coli by sublethal concentrations of streptomycin. J Clin Invest (1979) 2.10
Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect Immun (1981) 2.03
Detection of hepatitis A antigen by immunofluorescence. Infect Immun (1977) 2.00
The molecular virology of hepatitis C. Hepatology (1997) 2.00
Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci. J Exp Med (1980) 2.00
Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun (1982) 1.99
Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli. J Exp Med (1983) 1.96
Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med (1977) 1.95
Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol (1999) 1.93
Infections with Eikenella corrodens. A newly recognized human pathogen. Ann Intern Med (1974) 1.91
Taxonomic classification of hepatitis A virus. Intervirology (1983) 1.87
Molecular evolution of streptococcal M protein: cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes. J Bacteriol (1988) 1.86
Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology (1991) 1.82
Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J Exp Med (1983) 1.82
Bacterial adherence. Adv Intern Med (1980) 1.80
Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J Virol (1994) 1.80
Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest (1991) 1.77
Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci. J Bacteriol (1985) 1.77
Binding of streptococcal lipoteichoic acid to the fatty acid binding sites on serum albumin. J Biol Chem (1980) 1.75
Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest (1973) 1.74
Peptic digestion of streptococcal M protein. I. Effect of digestion at suboptimal pH upon the biological and immunochemical properties of purified M protein extracts. Infect Immun (1974) 1.74
Studies of antibodies to non-type-specific antigens associated with streptococcal M protein in the sera of patients with rheumatic fever. J Immunol (1973) 1.73
Correlation of virology and clinical course of cytomegalovirus retinitis. Am J Ophthalmol (1972) 1.72
Primary structural similarities between types 5 and 24 M proteins of Streptococcus pyogenes. Biochem Biophys Res Commun (1980) 1.72
CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol (1995) 1.72
Immunochemical properties of streptococcal M protein purified by isoelectric focusing. J Immunol (1975) 1.72
Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun (1985) 1.71
Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J Exp Med (1986) 1.71
Superantigenicity of streptococcal M protein. J Exp Med (1990) 1.70
An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol (1994) 1.68
Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A (1984) 1.67
Hydrophobic interactions of group A streptococci with hexadecane droplets. J Bacteriol (1983) 1.67
Suppression of bacterial adherence by subminimal inhibitory concentrations of beta-lactam and aminoglycoside antibiotics. Rev Infect Dis (1980) 1.67
Changes in small airway function after live attenuated influenza vaccination. Am Rev Respir Dis (1975) 1.66
Erythrocyte binding properties of streptococcal lipoteichoic acids. Infect Immun (1979) 1.65
Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun (1977) 1.65
Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med (1985) 1.65
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med (1972) 1.64
Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med (1988) 1.63